SCHEMBL22011547

SCHEMBL22011547

c1ccc(-n2c3ccccc3c3c2c2ccc4sc5ccccc5c4c2c2c4ccccc4n(-c4ccccc4)c23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.39
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
ALDH1A1 P00352 4/20 0.35
GAA P10253 2/20 0.35
GPR3 P46089 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE3A Q14432 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
MAPT P10636 3/20 0.33
POLB P06746 1/20 0.33
DUSP3 P51452 1/20 0.33
BLM P54132 1/20 0.33
PTPN5 P54829 1/20 0.33
PTPN11 Q06124 1/20 0.33
MCL1 Q07820 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18687894 0.92 ATM (0.42) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL22011429 0.91 ATM (0.39) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL24171791 0.90 ATM (0.43) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL10014541 0.87 ATM (0.50) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL18687908 0.85 KDM4E (0.41) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL16870209 0.84 ATM (0.43) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL18687900 0.84 L3MBTL1 (0.35) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL22012990 0.84 ALDH1A1 (0.39) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL21116958 0.83 ATM (0.41) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL22662505 0.83 ATM (0.41) ATML3MBTL1KDM4EHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 ATM 1787/4885L3MBTL1 2301/4885KDM4E 1792/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 ATM 1787/4885L3MBTL1 2301/4885KDM4E 1792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.